| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 4.74e-05 | 3 | 80 | 2 | GO:0018858 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 7.82e-05 | 21 | 80 | 3 | GO:0016408 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 9.46e-05 | 4 | 80 | 2 | GO:0102391 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 4.37e-04 | 8 | 80 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 7.78e-04 | 45 | 80 | 3 | GO:0043495 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 8.52e-04 | 11 | 80 | 2 | GO:0031956 | |
| Domain | Spectrin | 3.01e-06 | 23 | 83 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 7.91e-06 | 29 | 83 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.19e-05 | 32 | 83 | 4 | IPR018159 | |
| Domain | SPEC | 1.19e-05 | 32 | 83 | 4 | SM00150 | |
| Domain | NfI_DNAbd_pre-N | 1.16e-04 | 4 | 83 | 2 | PF10524 | |
| Domain | CTF_NFI | 1.16e-04 | 4 | 83 | 2 | PF00859 | |
| Domain | CTF_NFI_1 | 1.16e-04 | 4 | 83 | 2 | PS00349 | |
| Domain | CTF/NFI | 1.16e-04 | 4 | 83 | 2 | IPR000647 | |
| Domain | CTF_NFI_2 | 1.16e-04 | 4 | 83 | 2 | PS51080 | |
| Domain | CTF/NFI_DNA-bd_N | 1.16e-04 | 4 | 83 | 2 | IPR019548 | |
| Domain | CTF/NFI_DNA-bd_CS | 1.16e-04 | 4 | 83 | 2 | IPR019739 | |
| Domain | CTF/NFI_DNA-bd-dom | 1.16e-04 | 4 | 83 | 2 | IPR020604 | |
| Domain | Actinin_actin-bd_CS | 1.41e-04 | 23 | 83 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 1.41e-04 | 23 | 83 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.41e-04 | 23 | 83 | 3 | PS00019 | |
| Domain | HSR | 1.93e-04 | 5 | 83 | 2 | PS51414 | |
| Domain | HSR | 1.93e-04 | 5 | 83 | 2 | PF03172 | |
| Domain | HSR_dom | 1.93e-04 | 5 | 83 | 2 | IPR004865 | |
| Domain | SAND_dom | 5.37e-04 | 8 | 83 | 2 | IPR000770 | |
| Domain | SAND | 5.37e-04 | 8 | 83 | 2 | PF01342 | |
| Domain | SAND | 5.37e-04 | 8 | 83 | 2 | PS50864 | |
| Domain | SAND | 5.37e-04 | 8 | 83 | 2 | SM00258 | |
| Domain | MAD_homology1_Dwarfin-type | 1.25e-03 | 12 | 83 | 2 | IPR003619 | |
| Domain | DWA | 1.25e-03 | 12 | 83 | 2 | SM00523 | |
| Domain | - | 1.25e-03 | 12 | 83 | 2 | 3.10.390.10 | |
| Domain | SAND_dom-like | 1.25e-03 | 12 | 83 | 2 | IPR010919 | |
| Domain | MH1 | 1.25e-03 | 12 | 83 | 2 | PF03165 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.72e-03 | 14 | 83 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.72e-03 | 14 | 83 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.72e-03 | 14 | 83 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.72e-03 | 14 | 83 | 2 | PF08393 | |
| Domain | MT | 1.72e-03 | 14 | 83 | 2 | PF12777 | |
| Domain | AAA_8 | 1.72e-03 | 14 | 83 | 2 | PF12780 | |
| Domain | DHC_fam | 1.97e-03 | 15 | 83 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.97e-03 | 15 | 83 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.97e-03 | 15 | 83 | 2 | PF03028 | |
| Domain | AMP-bd_C | 2.54e-03 | 17 | 83 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 2.54e-03 | 17 | 83 | 2 | PF13193 | |
| Domain | CH | 3.03e-03 | 65 | 83 | 3 | SM00033 | |
| Domain | CH | 3.74e-03 | 70 | 83 | 3 | PF00307 | |
| Domain | - | 3.89e-03 | 71 | 83 | 3 | 1.10.418.10 | |
| Domain | CH | 4.21e-03 | 73 | 83 | 3 | PS50021 | |
| Domain | CH-domain | 4.54e-03 | 75 | 83 | 3 | IPR001715 | |
| Domain | AMP-binding_CS | 5.92e-03 | 26 | 83 | 2 | IPR020845 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 1.91e-05 | 39 | 58 | 4 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 2.11e-05 | 40 | 58 | 4 | M41816 | |
| Pathway | REACTOME_UTILIZATION_OF_KETONE_BODIES | 9.93e-05 | 4 | 58 | 2 | MM15459 | |
| Pathway | WP_DISORDERS_IN_KETOLYSIS | 1.65e-04 | 5 | 58 | 2 | M48310 | |
| Pathway | WP_SYNTHESIS_AND_DEGRADATION_OF_KETONE_BODIES | 1.65e-04 | 5 | 58 | 2 | MM15883 | |
| Pathway | WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS | 1.65e-04 | 5 | 58 | 2 | M45560 | |
| Pathway | BIOCARTA_LDL_PATHWAY | 2.47e-04 | 6 | 58 | 2 | M22051 | |
| Pathway | REACTOME_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE | 2.47e-04 | 6 | 58 | 2 | MM14693 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 3.45e-04 | 7 | 58 | 2 | MM14598 | |
| Pathway | KEGG_BUTANOATE_METABOLISM | 3.61e-04 | 34 | 58 | 3 | M3397 | |
| Pathway | REACTOME_SYNTHESIS_OF_KETONE_BODIES | 4.58e-04 | 8 | 58 | 2 | M27718 | |
| Pathway | WP_KETOGENESIS_AND_KETOLYSIS | 4.58e-04 | 8 | 58 | 2 | M39836 | |
| Pathway | REACTOME_SYNTHESIS_OF_KETONE_BODIES | 4.58e-04 | 8 | 58 | 2 | MM15460 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 4.65e-04 | 37 | 58 | 3 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 4.65e-04 | 37 | 58 | 3 | MM15610 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 5.88e-04 | 9 | 58 | 2 | M26968 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 7.33e-04 | 10 | 58 | 2 | MM15112 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 7.33e-04 | 10 | 58 | 2 | MM15437 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PI3P_SYNTHESIS_BY_PI3KC3_C1 | 7.33e-04 | 10 | 58 | 2 | M47974 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 7.33e-04 | 10 | 58 | 2 | M27706 | |
| Pathway | WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER | 1.34e-03 | 53 | 58 | 3 | M39688 | |
| Pathway | WP_8P231_COPY_NUMBER_VARIATION_SYNDROME | 1.41e-03 | 54 | 58 | 3 | M48073 | |
| Pathway | PID_TGFBR_PATHWAY | 1.41e-03 | 54 | 58 | 3 | M286 | |
| Pubmed | DST ACAT1 SPTAN1 SPTBN1 SYNE2 USP24 PUM3 SERPINH1 DYNC1H1 RRP1 | 4.49e-06 | 653 | 85 | 10 | 22586326 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16521160 | ||
| Pubmed | Identification of a mouse brain beta-spectrin cDNA and distribution of its mRNA in adult tissues. | 5.90e-06 | 2 | 85 | 2 | 1742606 | |
| Pubmed | Transcriptional diversity during lineage commitment of human blood progenitors. | 5.90e-06 | 2 | 85 | 2 | 25258084 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19634011 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25099615 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 29948332 | ||
| Pubmed | Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease. | 5.90e-06 | 2 | 85 | 2 | 36130593 | |
| Pubmed | Spectrin-actin interaction is required for neurite extension in NB 2a/dl neuroblastoma cells. | 5.90e-06 | 2 | 85 | 2 | 8776664 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8406479 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35952671 | ||
| Pubmed | The role of Sp140 revealed in IgE and mast cell responses in Collaborative Cross mice. | 5.90e-06 | 2 | 85 | 2 | 34156030 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PTK2B DST USP22 SPTAN1 SPTBN1 SYNE2 RALGAPB LARP1B RAB21 SERPINH1 DNAH7 | 8.09e-06 | 861 | 85 | 11 | 36931259 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.18e-05 | 120 | 85 | 5 | 31413325 | |
| Pubmed | 1.45e-05 | 591 | 85 | 9 | 15231748 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 8479293 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 18809517 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10576550 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9099724 | ||
| Pubmed | Developmental expression of brain beta-spectrin isoform messenger RNAs. | 1.77e-05 | 3 | 85 | 2 | 1467942 | |
| Pubmed | alpha -Catenin binds directly to spectrin and facilitates spectrin-membrane assembly in vivo. | 1.77e-05 | 3 | 85 | 2 | 11069925 | |
| Pubmed | 1.77e-05 | 332 | 85 | 7 | 37433992 | ||
| Pubmed | 2.50e-05 | 484 | 85 | 8 | 31995728 | ||
| Pubmed | 2.65e-05 | 638 | 85 | 9 | 31182584 | ||
| Pubmed | SLX9 GNL3L ACAD11 SPTAN1 SPTBN1 PUM3 ZCCHC17 LARP1B QARS1 RAB21 BDH1 DYNC1H1 RRP1 | 2.77e-05 | 1371 | 85 | 13 | 36244648 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 34151776 | ||
| Pubmed | Nuclear factor one transcription factors as epigenetic regulators in cancer. | 3.53e-05 | 4 | 85 | 2 | 28076901 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 3.53e-05 | 4 | 85 | 2 | 3862089 | |
| Pubmed | Transcription factor NF 1 expression in involuting mammary gland. | 3.53e-05 | 4 | 85 | 2 | 10959417 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 7590749 | ||
| Pubmed | The SUN2-nesprin-2 LINC complex and KIF20A function in the Golgi dispersal. | 3.53e-05 | 4 | 85 | 2 | 33686165 | |
| Pubmed | RFX1 and NF-1 associate with P sequences of the human growth hormone locus in pituitary chromatin. | 3.53e-05 | 4 | 85 | 2 | 12624117 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 17088250 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 32830538 | ||
| Pubmed | Brain beta spectrin isoform 235 (Spnb-2) maps to mouse chromosome 11. | 3.53e-05 | 4 | 85 | 2 | 1638088 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 9052991 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 9056636 | ||
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 3.53e-05 | 4 | 85 | 2 | 12820899 | |
| Pubmed | Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. | 3.53e-05 | 4 | 85 | 2 | 11036077 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12568726 | ||
| Pubmed | 3.58e-05 | 151 | 85 | 5 | 17043677 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 21791085 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 20858899 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 22632975 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 24608080 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 11274145 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 35733270 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 19706729 | ||
| Pubmed | 7.29e-05 | 33 | 85 | 3 | 26025364 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 9211987 | ||
| Pubmed | ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors. | 8.80e-05 | 6 | 85 | 2 | 37069398 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 21346257 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 21270437 | ||
| Pubmed | 1.09e-04 | 191 | 85 | 5 | 33762435 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | KIF20A SLX9 GNL3L DST ACAT1 SPTAN1 SPTBN1 PUM3 ERI1 QARS1 SERPINH1 DYNC1H1 | 1.09e-04 | 1353 | 85 | 12 | 29467282 |
| Pubmed | 1.18e-04 | 102 | 85 | 4 | 10231032 | ||
| Pubmed | Host cell targets of tegument protein VP22 of herpes simplex virus 1. | 1.23e-04 | 7 | 85 | 2 | 21424732 | |
| Pubmed | ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ-PP2A. | 1.23e-04 | 7 | 85 | 2 | 21460856 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 10698523 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 10762365 | ||
| Pubmed | TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence. | 1.23e-04 | 7 | 85 | 2 | 25220407 | |
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 11956189 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 17245430 | ||
| Pubmed | ASXL1 DST USP22 ACACB NFIB NFIC SPTAN1 SPTBN1 SYNE2 PUM3 QARS1 DYNC1H1 | 1.82e-04 | 1429 | 85 | 12 | 35140242 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.99e-04 | 1024 | 85 | 10 | 24711643 | |
| Pubmed | 2.10e-04 | 493 | 85 | 7 | 15368895 | ||
| Pubmed | Formin 2 Regulates Lysosomal Degradation of Wnt-Associated β-Catenin in Neural Progenitors. | 2.10e-04 | 9 | 85 | 2 | 29659741 | |
| Pubmed | High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12. | 2.10e-04 | 9 | 85 | 2 | 16309881 | |
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 16551741 | ||
| Pubmed | Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis. | 2.10e-04 | 9 | 85 | 2 | 38029747 | |
| Pubmed | 2.33e-04 | 225 | 85 | 5 | 12168954 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.52e-04 | 358 | 85 | 6 | 32460013 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.62e-04 | 10 | 85 | 2 | 22159418 | |
| Pubmed | USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. | 2.62e-04 | 10 | 85 | 2 | 36653359 | |
| Pubmed | Generation and analysis of 280,000 human expressed sequence tags. | 2.92e-04 | 368 | 85 | 6 | 8889549 | |
| Pubmed | PLEKHH1 FAIM DST SACS MTIF2 SPTAN1 SPTBN1 DNAI7 QARS1 SMURF2 DYNC1H1 | 2.93e-04 | 1285 | 85 | 11 | 35914814 | |
| Pubmed | 2.97e-04 | 237 | 85 | 5 | 29564676 | ||
| Pubmed | DST ACAT1 NFIC SPTAN1 LPL SYNE2 USP24 QARS1 RAB21 SERPINH1 DYNC1H1 | 3.17e-04 | 1297 | 85 | 11 | 33545068 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 3.20e-04 | 11 | 85 | 2 | 17607528 | |
| Pubmed | Nfix regulates fetal-specific transcription in developing skeletal muscle. | 3.20e-04 | 11 | 85 | 2 | 20178747 | |
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 36411454 | ||
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 3.20e-04 | 11 | 85 | 2 | 16815997 | |
| Pubmed | Analysis of the DNA sequence and duplication history of human chromosome 15. | 3.56e-04 | 56 | 85 | 3 | 16572171 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ACACB ACAT1 USP24 ZCCHC17 ERI1 QARS1 RAB21 SERPINH1 BDH1 DYNC1H1 RRP1 | 3.63e-04 | 1318 | 85 | 11 | 30463901 |
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 11867214 | ||
| Pubmed | 4.21e-04 | 730 | 85 | 8 | 34857952 | ||
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 18796539 | ||
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 17553984 | ||
| Pubmed | Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression. | 4.52e-04 | 13 | 85 | 2 | 35913115 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.17e-04 | 410 | 85 | 6 | 26949251 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 5.21e-04 | 949 | 85 | 9 | 36574265 | |
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 9373155 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.44e-04 | 759 | 85 | 8 | 35915203 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 5.46e-04 | 271 | 85 | 5 | 25737280 | |
| Pubmed | 6.03e-04 | 277 | 85 | 5 | 30745168 | ||
| Pubmed | 6.07e-04 | 15 | 85 | 2 | 19703589 | ||
| Pubmed | 6.34e-04 | 777 | 85 | 8 | 35844135 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 6.43e-04 | 281 | 85 | 5 | 28706196 | |
| Pubmed | 6.75e-04 | 284 | 85 | 5 | 29459677 | ||
| GeneFamily | EF-hand domain containing|Spectrins | 2.10e-04 | 7 | 58 | 2 | 1113 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 PPP2R5C DST SACS NFIB MTIF2 SYNE2 USP24 PUM3 RAB21 CBLB SMURF2 CREB5 | 2.44e-06 | 856 | 82 | 13 | M4500 |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN | 2.78e-06 | 196 | 82 | 7 | M8757 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 6.74e-06 | 84 | 82 | 5 | M13008 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 1.75e-05 | 474 | 82 | 9 | M40991 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.90e-08 | 196 | 85 | 7 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 85 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 85 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 85 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | droplet-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 196 | 85 | 6 | b880c9665d42c76ea1971d4e49d7ecf72fcfafb6 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.14e-06 | 197 | 85 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | COVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.14e-06 | 197 | 85 | 6 | 39ee4b93625c994813044d8dd8854fba2bd99940 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.27e-06 | 199 | 85 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 2.27e-06 | 199 | 85 | 6 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.34e-06 | 200 | 85 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.34e-06 | 200 | 85 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.34e-06 | 200 | 85 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.34e-06 | 200 | 85 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.34e-06 | 200 | 85 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.34e-06 | 200 | 85 | 6 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 153 | 85 | 5 | 499670e716fc85ce76630fc813cec86f8419f2a1 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 175 | 85 | 5 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.14e-05 | 175 | 85 | 5 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 176 | 85 | 5 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.59e-05 | 182 | 85 | 5 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.59e-05 | 182 | 85 | 5 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-05 | 182 | 85 | 5 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-05 | 182 | 85 | 5 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 2.66e-05 | 183 | 85 | 5 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.66e-05 | 183 | 85 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.73e-05 | 184 | 85 | 5 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 184 | 85 | 5 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.02e-05 | 188 | 85 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 189 | 85 | 5 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 189 | 85 | 5 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.10e-05 | 189 | 85 | 5 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 190 | 85 | 5 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 190 | 85 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 191 | 85 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-05 | 191 | 85 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-05 | 191 | 85 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 191 | 85 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 191 | 85 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.34e-05 | 192 | 85 | 5 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 194 | 85 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.60e-05 | 195 | 85 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 3.60e-05 | 195 | 85 | 5 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.60e-05 | 195 | 85 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.60e-05 | 195 | 85 | 5 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 196 | 85 | 5 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.69e-05 | 196 | 85 | 5 | 0175b097ad1338a07afebe3b5c7fd0bb0bb950f7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 197 | 85 | 5 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-05 | 197 | 85 | 5 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 197 | 85 | 5 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.78e-05 | 197 | 85 | 5 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 197 | 85 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 197 | 85 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.87e-05 | 198 | 85 | 5 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | ASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.87e-05 | 198 | 85 | 5 | e282769f5fa1765bcce79a0ed9d761bf2e14b012 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 3.87e-05 | 198 | 85 | 5 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-gd_T|Leuk-UTI / Disease, condition lineage and cell class | 3.96e-05 | 199 | 85 | 5 | b2c1b9ee764e1246bfa3ecf666ca76ae4ac6c362 | |
| ToppCell | control-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.96e-05 | 199 | 85 | 5 | 50e2da35edff1aadef939cfbd4549f73c1a07717 | |
| ToppCell | ASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.96e-05 | 199 | 85 | 5 | 0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5 | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.96e-05 | 199 | 85 | 5 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.06e-05 | 200 | 85 | 5 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-dn_T|COVID-19_Severe / Disease, condition lineage and cell class | 4.06e-05 | 200 | 85 | 5 | d01aa5fccada22f97d8350ad5888df2aadb5bb1c | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.06e-05 | 200 | 85 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 200 | 85 | 5 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Sst_(Striatum,_interneuron)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.96e-04 | 59 | 85 | 3 | 0946b53be12a9926d876c75ddf5dec414a4f8063 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Sst_(Striatum,_interneuron)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.96e-04 | 59 | 85 | 3 | 5da8beaf3c690861d5561ae40d4ff7c2d3732ef4 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Sst_(Striatum,_interneuron)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.96e-04 | 59 | 85 | 3 | 1c26fabefafd4ce05f21750ae69895c488ea1a11 | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | 2.00e-04 | 151 | 85 | 4 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 2.26e-04 | 156 | 85 | 4 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-04 | 157 | 85 | 4 | 170197b76620df31495f1247f365da382b2d8045 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-04 | 157 | 85 | 4 | c21520301cc0d5d4b1cc4b8ec735f9adb698e768 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.38e-04 | 158 | 85 | 4 | 7274f020c0ecf216da4b6689c62bc5f49c29b6f3 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 2.49e-04 | 160 | 85 | 4 | d288b0a315f6adc0be4bdc89fa67bf93679a743f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 162 | 85 | 4 | 9b1c07f0af657095379380c39d763cab0ad73e74 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.00e-04 | 168 | 85 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.21e-04 | 171 | 85 | 4 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-04 | 171 | 85 | 4 | e6dfbd2652b67577c8834c05348f62150637f348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-04 | 171 | 85 | 4 | ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 173 | 85 | 4 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 175 | 85 | 4 | 7329ebb135fc4311ee9595729b62a5d152c9de8c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.58e-04 | 176 | 85 | 4 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 3.58e-04 | 176 | 85 | 4 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-04 | 177 | 85 | 4 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | IIF-Lymphocyte-T_NK-MAIT|IIF / Disease, Lineage and Cell Type | 3.74e-04 | 178 | 85 | 4 | be777ebef8f09a1a16fcee8fc69a65ab295b6e1d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.74e-04 | 178 | 85 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 3.98e-04 | 181 | 85 | 4 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.15e-04 | 183 | 85 | 4 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 183 | 85 | 4 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 183 | 85 | 4 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 184 | 85 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 184 | 85 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 184 | 85 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-04 | 185 | 85 | 4 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 4.41e-04 | 186 | 85 | 4 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 186 | 85 | 4 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 186 | 85 | 4 | f28d72b47624b69a580b4429e2be560a26898591 | |
| Drug | AC1NUTWC | 1.86e-07 | 4 | 83 | 3 | CID005460914 | |
| Disease | X-21319 measurement | 7.44e-06 | 2 | 81 | 2 | EFO_0800807 | |
| Disease | X-11478 measurement | 2.23e-05 | 3 | 81 | 2 | EFO_0021242 | |
| Disease | 3-hydroxyhexanoate measurement | 7.40e-05 | 5 | 81 | 2 | EFO_0800378 | |
| Disease | indoleacetoylcarnitine measurement | 1.11e-04 | 6 | 81 | 2 | EFO_0800106 | |
| Disease | volumetric bone mineral density | 2.12e-04 | 42 | 81 | 3 | EFO_0007620 | |
| Disease | Liver Cirrhosis, Experimental | 2.71e-04 | 774 | 81 | 9 | C0023893 | |
| Disease | salicylate measurement | 4.03e-04 | 11 | 81 | 2 | EFO_0021161 | |
| Disease | colorectal cancer, inflammatory bowel disease | 1.23e-03 | 19 | 81 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | alkaline phosphatase measurement | 1.85e-03 | 1015 | 81 | 9 | EFO_0004533 | |
| Disease | urinary uromodulin measurement | 2.37e-03 | 96 | 81 | 3 | EFO_0005663 | |
| Disease | upper face morphology measurement | 2.44e-03 | 97 | 81 | 3 | EFO_0010949 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLKKVIDWMKLKELG | 206 | Q8IV48 | |
| FLPQKKMIKEQIEWL | 746 | Q93034 | |
| LVGMEIWTDKDKIKI | 251 | Q9UKQ2 | |
| IAKKMWEELPEVVRK | 256 | Q02338 | |
| EFQKEVLKAMEGKWI | 91 | Q6ZNE5 | |
| GKIQRAKLRDKEWKM | 556 | Q08AH3 | |
| ETKEEKRWKEMKLQV | 136 | Q12887 | |
| LKMKEREEAWVKIEN | 421 | Q13362 | |
| KWMNVKVGDIIKLEN | 126 | Q8TF62 | |
| RIRQEMEKEKKVEQW | 336 | Q8IXJ9 | |
| IDKLKEMAKVEGLWN | 421 | Q709F0 | |
| KNWVKELRKMLGNEI | 111 | Q9UL25 | |
| KVWRLDLVMVILFKG | 126 | O00712 | |
| LVLKWLIEQDKKMKE | 556 | Q15397 | |
| KVQEEMARKKERGLW | 606 | Q8IXQ6 | |
| RMLEKGVISDILEWK | 2306 | O00763 | |
| RMEKIVLEKVCWKVK | 136 | P51959 | |
| KIWKRMKQKLLDEVI | 1556 | O60840 | |
| RKVWVMSLEKKAEEL | 396 | Q02930 | |
| VWIKEVITKAGMKLK | 136 | P46199 | |
| RTFKGLMILIEKEWI | 361 | Q96EF0 | |
| RQRLKEEKLEMLQWK | 141 | Q96S65 | |
| NDIEKEWGKLIIAML | 356 | Q03001 | |
| EWGKLIIAMLEREKA | 361 | Q03001 | |
| RWRKQKVEMELPGDK | 796 | O43451 | |
| VEKTWKLMDKVVRLC | 46 | Q13191 | |
| EVDIGELLMLKLKWK | 396 | P06858 | |
| WKIMQKKIEELCREV | 36 | Q6ZU52 | |
| MWKQEEKIREQEEKI | 581 | A8MZA4 | |
| KIREQEEIWRQKEKM | 406 | H0YM25 | |
| MWKQEEKIREQEEKI | 556 | H0YM25 | |
| ISRAWKKILPMVEEK | 381 | Q9Y4A0 | |
| KEELKRKVEMWQKEL | 606 | A2A3K4 | |
| LRMEEKWLLKGKLRN | 46 | C9JSJ3 | |
| LMKKLKEQLEERTWL | 376 | Q8IV76 | |
| GLQIDWEKIKAKIEM | 741 | Q9P2H3 | |
| WEKIKAKIEMEITKE | 746 | Q9P2H3 | |
| DPLKKEMEEVWKIVR | 871 | A6NNT2 | |
| KIMQWIIEGEKEISR | 631 | O15169 | |
| KQMREWEGKLLLLQE | 961 | Q8WXX0 | |
| GKEEIRKEWMFKLVG | 36 | Q9NVQ4 | |
| KGWMIVEILKEGLQK | 401 | Q6TDU7 | |
| KQGLEMRIKLWEEIK | 141 | Q8NA03 | |
| DIVKRKREENLKMVW | 436 | Q14204 | |
| VILGDRWKKMKNEER | 466 | O60381 | |
| EEAVLKKMIEFIGWK | 156 | Q6ZQY3 | |
| LWEAEKVKMRQILDK | 796 | Q14289 | |
| LKKEKQDMRWVEQLE | 266 | I6L899 | |
| KIMVLGANWKEVLLK | 216 | O76054 | |
| IKLVQLGMAKDDILW | 2146 | Q9NZJ4 | |
| IVDEKMRKKIEPEKW | 281 | Q659C4 | |
| DLEVKDWMQKKRRGL | 151 | Q9UJX0 | |
| KERKVWVKENMVLNL | 436 | P43121 | |
| VLKWADGKMIKNEVD | 156 | P47897 | |
| AELQMKRIWGEKEKK | 2686 | Q8WXH0 | |
| QLVLQEWKKERKEMR | 451 | Q86UY8 | |
| EAELKKKWVEEMREK | 56 | Q9NVN8 | |
| LEKLLTKEQLKIWMG | 281 | P50454 | |
| IIEFKKLANWKEEEM | 106 | Q9Y2E8 | |
| KVLKMQGWEERQIEE | 131 | P56182 | |
| VLKDVGLKKEDIAMW | 336 | P24752 | |
| KVMIWDDLKKKTVIE | 81 | Q5MNZ6 | |
| DENIKRKWVLAMKRL | 31 | Q8TBB0 | |
| KVWRLDLVMVILFKG | 126 | P08651 | |
| QGLKEPMWLDKIKKR | 506 | Q9H930 | |
| RQRWLVELGKLEEKM | 366 | Q499Z3 | |
| NKEWLDKIEKEGMQL | 1326 | Q01082 | |
| GKIQRTKLRDKEWKM | 556 | Q68CK6 | |
| KDLWKRLMIKFRGEE | 416 | Q9HAU4 | |
| IIAKEEQRKAWKMQG | 126 | Q9UPT9 | |
| QLPWRKIKDKEQVGM | 236 | Q5TCY1 | |
| KVWVKLIGREMKNDR | 66 | Q9NP64 | |
| VKEMVKDVLKGQNWL | 141 | O95235 | |
| WLDSKQIRQEEMKKL | 211 | O95235 | |
| LIWQKVDEVMTKEIK | 241 | Q9NWX6 | |
| WVVETLCGLKMKLKR | 81 | A6NLX3 | |
| RREELLKKMQSLWEK | 136 | Q9BSJ1 | |
| WELLLEKMREKGIKL | 131 | Q13813 | |
| VLPKKEKMKLRREQW | 101 | Q9NSI2 | |
| EKMKLRREQWLQKIE | 106 | Q9NSI2 | |
| LLKTDKEVKWTMEVI | 56 | Q86X10 | |
| IKEWVTLKLAKLEME | 131 | Q9ULM0 | |
| EKLELIGMDFIWKIA | 816 | Q9UPU5 | |
| KEPMWLDKIKKRLNE | 796 | Q13342 | |
| DREKLLKQMRILWKK | 136 | A6NCK2 | |
| WLMKTETRLKKEGIV | 2881 | O15050 | |
| WGKVPRKDLIVMLKD | 186 | Q6S545 | |
| IEKKMKLAQKRERWI | 1806 | Q6ZQQ6 | |
| MIKLIREDGGWKQLE | 176 | Q86TJ5 | |
| RVMEELLKWGEELGK | 611 | Q86W25 |